Ziftomenib | m-entrepreneurship.com

Product Name :
Ziftomenib

Search keywords :
MI-463

drugId :
null

Target Vo:
Menin

Target Vo Short Name :
MEN1

Moa_Name:
Menin inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Kura Oncology Inc

Active Company_Name :
Kura Oncology Inc

Active Indication_Name:
Precursor Cell Lymphoblastic Leukemia-Lymphoma

In Active Indication_Name:
Neoplasms

Termination Status :

China Termination Status :

Highest Status:
Phase 2 Clinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
RhoA Antibody
Doublecortin Antibody
Phospho-Histone H2A.X (Ser139) Antibody: Phospho-Histone H2A.X (Ser139) Antibody is a non-conjugated and Mouse origined monoclonal antibody about 15 kDa, targeting to Histone H2AX. It can be used for WB,ICC/IF assays with N-6*His-tag, in the background of Human, Mouse.

Author: Betaine hydrochloride

Related Posts